Celera is a biotechnology company that focuses on drug discovery and development. They aim to accelerate the process of discovering new therapies through advanced genomic analysis and personalized medicine.
In 1998, Celera Genomics was formed as a subsidiary of the Applied Biosystems Group.
Celera Genomics became known for its efforts in sequencing the human genome, being a competitor to the publicly funded Human Genome Project.
In 2008, Celera sold its diagnostic business to Quest Diagnostics and shifted its focus towards drug discovery.
In 2011, Quest Diagnostics acquired Celera Genomics.
In 2018, Quest Diagnostics sold its Celera business to Precision Medicine Group.
Celera currently operates as a division of Precision Medicine Group.
Illumina is a leading provider of next-generation sequencing technologies and services. They offer a wide range of genomic solutions for research, clinical, and applied markets.
Thermo Fisher Scientific is a biotechnology company that provides scientific research services, laboratory equipment, and diagnostics products. They have a strong focus on life sciences and genetic analysis.
Roche Diagnostics is a global leader in in-vitro diagnostics and molecular diagnostics. They offer a wide range of testing solutions and systems for healthcare professionals and researchers.
Celera offers genomic sequencing services using advanced technologies to provide accurate and comprehensive genomic data for research and clinical applications.
Celera has developed a drug discovery platform that leverages genomics and bioinformatics to identify potential drug targets and accelerate the development of novel therapies.
Celera provides precision medicine solutions by analyzing individual genetic information to help healthcare professionals tailor treatments based on the patient's genetic profile.
Celera's primary focus is on drug discovery and development through advanced genomic analysis and personalized medicine.
Celera is currently owned by Precision Medicine Group, a healthcare research and insights company.
Celera offers genomic sequencing services, a drug discovery platform, and precision medicine solutions.
Some of Celera's competitors include Illumina, Thermo Fisher Scientific, and Roche Diagnostics.
Celera contributes to personalized medicine by analyzing individual genetic information and providing tailored treatment options based on the patient's genetic profile.